Skip to main content
Year archive

Keymed Biosciences Inc. — 2022 filings

All 72 regulatory filings released by Keymed Biosciences Inc. (2162) in 2022, sourced directly from the official regulator.

72 Filings
2022 Period
2022 filings (72)
Filing Released Lang
Terms of Reference of the Remuneration Committee
Remuneration Information
2022-12-12 English
Interim Report 2022/23
Regulatory Filings
2022-12-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-01 English
Cash Dividend Announcement for Equity Issuer
Notice of Dividend Amount
2022-11-28 English
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2022
Interim / Quarterly Report
2022-11-28 English
DATE OF BOARD MEETING
Regulatory Filings
2022-11-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-01 English
Termination Agreement
Regulatory Filings
2022-10-26 English
MAJOR TRANSACTION / TERMINATION OF COOPERATION AGREEMENT / DISPOSAL OF EQUITY INTERESTS
Proxy Solicitation & Information Statement
2022-10-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-07 English
DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO THE TERMINATION OF THE COOPERATION AGREEMENT AND DISPOSAL OF EQUITY INTERESTS
Regulatory Filings
2022-10-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-05 English
2022 INTERIM REPORT
Interim / Quarterly Report
2022-09-20 English
VOLUNTARY ANNOUNCEMENT CMG901 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE CDE FOR THE TREATMENT OF CLAUDIN 18.2-POSITIVE ADVANCED GASTRIC CANCER THAT WAS RESISTANT/REFRACTORY OR INTOLERAN
Regulatory Filings
2022-09-19 English
MAJOR TRANSACTION / TERMINATION OF COOPERATION AGREEMENT / DISPOSAL OF EQUITY INTERESTS
Capital/Financing Update
2022-09-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
Interim / Quarterly Report
2022-08-29 English
DATE OF BOARD MEETING
Report Publication Announcement
2022-08-17 English
Memorandum of Association and Bye-Laws
Regulatory Filings
2022-08-10 English
RESULTS OF ANNUAL GENERAL MEETING HELD ON 10 AUGUST 2022
Declaration of Voting Results & Voting Rights Announcements
2022-08-10 English
BAD WEATHER ARRANGEMENT FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 10 AUGUST 2022
AGM Information
2022-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-02 English
PRECAUTIONARY MEASURES FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 10 AUGUST 2022
AGM Information
2022-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-01 English
New share option scheme to be adopted by Suga International Holdings Limited
Regulatory Filings
2022-07-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-07-11 English
Proxy form for use at the Annual General Meeting to be held on Wednesday, 10 August 2022 at 3:00 p.m. or at any adjournment thereof
AGM Information
2022-07-11 English
PROPOSALS FOR RE-ELECTION OF DIRECTORS, ADOPTION OF THE NEW BYE-LAWS, ADOPTION OF NEW SHARE OPTION SCHEME, GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL
AGM Information
2022-07-11 English
ANNUAL REPORT 2021/22
Regulatory Filings
2022-07-11 English
DISCLOSEABLE TRANSACTION SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT
Capital/Financing Update
2022-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-05 English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2022-06-28 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 28, 2022
Declaration of Voting Results & Voting Rights Announcements
2022-06-28 English
Cash Dividend Announcement for Equity Issuer
Notice of Dividend Amount
2022-06-27 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2022
Annual Report
2022-06-27 English
Date of Board Meeting
Regulatory Filings
2022-06-15 English
VOLUNTARY ANNOUNCEMENT CM310 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE CENTER FOR DRUG EVALUATION OF NMPA FOR THE TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS
Regulatory Filings
2022-06-15 English
PROFIT WARNING
Regulatory Filings
2022-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-03 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2022-05-03 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-05-03 English
(1) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; (2) RE-ELECTION OF DIRECTORS&#x3b; (3) AMENDMENT OF THE ARTICLES OF ASSOCIATION&#x3b; (4) RE-APPOINTMENT OF AUDITOR&#x3b; AND (5) NOTIC
AGM Information
2022-05-03 English
PROPOSED ADOPTION OF REVISED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2022-04-27 English
2021 ANNUAL REPORT
Annual Report
2022-04-26 English
VOLUNTARY ANNOUNCEMENT CMG901 FOR THE TREATMENT OF RELAPSED/REFRACTORY GASTRIC CANCER AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WAS GRANTED THE FAST TRACK DESIGNATION BY THE FOOD AND DRUG ADMI
Regulatory Filings
2022-04-19 English
VOLUNTARY ANNOUNCEMENT CMG901 FOR THE TREATMENT OF GASTRIC CANCER AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WAS GRANTED THE ORPHAN-DRUG DESIGNATION BY THE FOOD AND DRUG ADMINISTRATION OF THE UNITED
Regulatory Filings
2022-04-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-01 English
VOLUNTARY ANNOUNCEMENT POSITIVE RESULT FROM PHASE II CLINICAL TRIAL OF CM310 AT CHRONIC SINUSITIS WITH NASAL POLYPS
Regulatory Filings
2022-03-30 English
CHANGE OF JOINT COMPANY SECRETARY AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information
2022-03-29 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
Annual Report
2022-03-29 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2022-03-29 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2022-03-29 English
DATE OF BOARD MEETING
Report Publication Announcement
2022-03-17 English
VOLUNTARY ANNOUNCEMENT UPDATE ON DEVELOPMENT PROJECT OF HUIZHOU JIAYIFU
Regulatory Filings
2022-03-09 English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS AN ELIGIBLE STOCK OF THE SHENZHEN-HONG KONG STOCK CONNECT
Capital/Financing Update
2022-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-01 English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT STOCK OF HANG SENG FAMILY OF INDEXES
Regulatory Filings
2022-02-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
SUPPLEMENTAL ANNOUNCEMENT REGARDING ADOPTION OF THE 2022 RESTRICTED SHARE UNIT SCHEME
Regulatory Filings
2022-01-28 English
ADOPTION OF THE 2022 RESTRICTED SHARE UNIT SCHEME
Share Issue/Capital Change
2022-01-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-03 English